CHAP 1. PREFACE
1.1. REPORT SCOPE AND DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1. PHASE I – SECONDARY RESEARCH
1.2.2. PHASE II – PRIMARY RESEARCH
1.2.3. PHASE III – EXPERT PANEL REVIEW
CHAP 2. EXECUTIVE SUMMARY
2.1. GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET SNAPSHOT
CHAP 3. GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET ANALYSIS
3.1. LATERAL EPICONDYLITIS TREATMENT MARKET OVERVIEW
3.2. MARKET INCLINATION INSIGHTS
3.2.1. SHOCKWAVE THERAPY: TREATMENT TYPE GROWING WITH A REMARKABLE RATE
3.2.2. OTHER TREATMENT TYPES SUCH AS PRP, SPLINT ELBOW BRACE, ICE PACKS, ETC. EXPECTED TO HOLD THE LARGEST MARKET SHARE.
3.3. MARKET DYNAMICS
3.3.1. MARKET DRIVERS
3.3.1.1. RISING SPORTS INJURIES
3.3.1.2. RISING PATIENT AWARENESS
3.3.1.3. RISING GERIATRIC POPULATION
3.3.2. RESTRAINTS
3.3.2.1. SIDE EFFECTS OF THE TREATMENT
3.3.2.2. EARLY RETIREMENT AGE OF PLAYERS
3.3.3. CHALLENGES
3.3.3.1. SLOW RESPONDING COMMERCIALIZATION OF NEW & EFFECTIVE THERAPIES
3.3.4. OPPORTUNITIES
3.3.4.1. TECHNOLOGICAL ADVANCEMENTS:
3.3.5. ATTRACTIVE INVESTMENT PROPOSITION, 2015
3.3.6. MARKET POSITIONING OF KEY MANUFACTURES
CHAP 4. GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET, BY TREATMENT TYPE, 2014 – 2022 (USD MN)
4.1. OVERVIEW
4.2. PAINKILLERS AND NSAIDS
4.3. CORTICOSTEROID INJECTIONS
4.4. SHOCK WAVE THERAPY
4.5. SURGERY
4.6. EQUIPMENT AND OTHER PRODUCTS
CHAP 5. GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET, BY PIPELINE TREATMENTS ASSESSMENT (QUALITATIVE INFORMATION)
5.1. OVERVIEW
5.2. PHASE I
5.3. PHASE II
5.4. PHASE III
CHAP 6. GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY GEOGRAPHY 2014 – 2022 ($ MILLION)
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. U.S.
6.2.2. CANADA
6.3. EUROPE
6.3.1. U.K.
6.3.2. GERMANY
6.3.3. REST OF EUROPE
6.4. ASIA-PACIFIC
6.4.1. JAPAN
6.4.2. CHINA
6.4.3. REST OF ASIA-PACIFIC
6.5. MIDDLE EAST AND AFRICA
6.6. LATIN AMERICA
CHAP 7. PROFILES
7.1. ARTHREX
7.2. TEIKOKU PHARMA
7.3. SEIKAGAKU CORPORATION
7.4. UNIPHAR GROUP
7.5. SMITH & NEPHEW
7.6. OTHERS
List of Tables
TABLE 1 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET 2014-2022 ($ MILLION) TABLE 2 SIDE-EFFECTS CAUSED BY NSAIDS
TABLE 3 SIDE EFFECTS OF CORTICOSTEROIDS
TABLE 4 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY TREATMENT TYPE 2014–2022 ($ MILLION)
TABLE 5 STUDY OF DRUG TRIALS RELATED TO LATERAL EPICONDYLITIS
TABLE 6 NORTH AMERICA LATERAL EPICONDYLITIS TREATMENT MARKET REVENUE ($ MILLION)
TABLE 7 SPORTS PARTICIPANTS IN U.S.
TABLE 8 SPORTS & ACTIVITIES PARTICIPANTS IN CANADA OF 3-17YEARS
TABLE 9 EUROPE LATERAL EPICONDYLITIS TREATMENT REVENUE ($ MILLION)
TABLE 10 PARTICIPATION OF U.K.IN SPORTS
TABLE 11 EUROPE LATERAL EPICONDYLITIS TREATMENT REVENUE ($ MILLION)
List of Figures
FIGURE 1 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET RESEARCH METHODOLOGY
FIGURE 2 MARKET SNAPSHOT: LATERAL EPICONDYLITIS TREATMENT MARKET
FIGURE 3 BENEFITS OF SHOCK WAVE THERAPY
FIGURE 4 OTHER TREATMENT TYPES (PRP, SPLINT ELBOW BRACE, ICE PACKS) MARKET 2014-2022
FIGURE 5 NUMBER OF INJURIES BY SPORTS AMONG CHILDREN AGES 19 AND UNDER, 2014
FIGURE 6 CHILDREN AGEING 5 TO 14 HOSPITALIZED DUE TO SPORTS INJURY (U.S. 2014)
FIGURE 7 PERCENTAGE OF POPULATION AGED OVER 60 YEARS OR OVER BY REGION IN 2015
FIGURE 8 PROPORTION OF POPULATION AGED 60 OR OVER IN 2014
FIGURE 9 COMMONLY USED NSAIDS, CORTICOSTEROIDS
FIGURE 10 ATTRACTIVE INVESTMENT PROPOSITION
FIGURE 11 TOP 3 PLAYERS OF GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET
FIGURE 12 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY PAINKILLERS & NSAIDS 2014-2022 ($ MILLION)
FIGURE 13 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY CORTICOSTEROID INJECTIONS 2014-2022 ($ MILLION)
FIGURE 14 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY SHOCK WAVE THERAPY 2014-2022 ($ MILLION)
FIGURE 15 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY SURGERY 2014-2022 ($ MILLION)
FIGURE 16 GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET BY EQUIPMENT AND OTHER PRODUCTS 2014-2022 ($ MILLION)
FIGURE 17 STAGES OF LATERAL EPICONDYLITIS TREATMENT PIPELINE
FIGURE 18 TANEZUMAB DETAILS
FIGURE 19 NORTH AMERICA REVENUE GENERATION IN LATERAL EPICONDYLITIS TREATMENT MARKET ($ MILLION)
FIGURE 20 PERCENTAGE OF POPULATION AGED 60 YEARS OR ABOVE IN NORTH AMERICA
FIGURE 21 MARKET SHARE OF NORTH AMERICA IN THE GLOBAL LATERAL EPICONDYLITIS TREATMENT MARKET.
FIGURE 22 COMPARATIVE ANALYSIS OF THE U.S.A. AND CANADA LATERAL EPICONDYLITIS (TENNIS ELBOW) MARKET 2015-2022 ($MILLION)
FIGURE 23 NORTH AMERICA LATERAL EPICONDYLITIS TREATMENT MARKET BY TREATMENT TYPE IN 2015
FIGURE 24 U.S. LATERAL EPICONDYLITIS TREATMENT MARKET 2014-2022 ($ MILLION)
FIGURE 25 POPULATION AGED 65 AND ABOVE IN UNITED STATES 2014-2022 (MILLION)
FIGURE 26 CANADA LATERAL EPICONDYLITIS TREATMENT MARKET, 2014-2022 ($MILLION)
FIGURE 27 EUROPE LATERAL EPICONDYLITIS TREATMENT MARKET 2014-2022 ($ MILLION)
FIGURE 28 NSAIDS CONSUMPTION BY REGIONS IN 2015
FIGURE 29 UK LATERAL EPICONDYLITIS TREATMENT MARKET, 2014-2022 ($MILLION)
FIGURE 30 GERMANY LATERAL EPICONDYLITIS MARKET, 2014-2022 ($MILLION)
FIGURE 31 GERMANY DEMOGRAPHICS (2015)
FIGURE 32 REST OF EUROPE LATERAL EPICONDYLITIS TREATMENT MARKET 2014-2022 ($ MILLION)
FIGURE 33 POPULATION IN RUSSIA (2015)
FIGURE 34 ASIA PACIFIC LATERAL EPICONDYLITIS TREATMENT MARKET BY REVENUE ($MILLION)
FIGURE 35 JAPAN LATERAL EPICONDYLITIS TREATMENT MARKET BY REVENUE ($MILLION) FIGURE 36 CHINA LATERAL EPICONDYLITIS TREATMENT MARKET BY REVENUE ($MILLION)
FIGURE 37 REST OF ASIA PACIFIC REGION LATERAL EPICONDYLITIS TREATMENT MARKET BY REVENUE ($MILLION)
FIGURE 38 MEA REVENUE GENERATION IN LATERAL EPICONDYLITIS TREATMENT MARKET ($MILLION)
FIGURE 39 PREFERRED THERAPEUTIC MANAGEMENT OF LATERAL EPICONDYLITIS IN MIDDLE EAST & AFRICA
FIGURE 40 CHINA LATERAL EPICONDYLITIS TREATMENT MARKET BY REVENUE ($MILLION)
FIGURE 41 PERCENTAGE OF PEOPLE OVER THE POPULATION IN LATIN AMERICA (AGE 60+ AND ABOVE)
